Luis Meza

Luis Meza

Auto-generated profile, based on publicly available information

Luis Meza

Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
LMLuis Meza
Luis Meza
MFMatthew Feng
Matthew Feng
KLKyle Osel Lee
Kyle Osel Lee
RSRubens Copia Sperandio
Rubens Copia Sperandio
SPSumanta K Pal
Sumanta K Pal
The introduction of targeted therapy (TT) and immuno-oncology (IO) agents have revolutionized the treatment of metastatic renal cell carcinoma (mRCC). However, despite the significant improvements in survival and clinical response yielded by these agents, a significant percentage of patients still experience progressive disease. Evidence now suggests that microorganisms living in the gut (i.e., the gut microbiome) could be used as a biomarker for response and may also have utility in increasing response to these treatments. In this review, we present an overview of the role of the gut microbiome in cancer and its potential implications in the treatment of mRCC.

2 September 2026
Verified
Book Chapter
Closed access
PDF file
JMJasnoor Malhotra
Jasnoor Malhotra
LMLuis Meza
Luis Meza
AGAmeish Govindarajan
Ameish Govindarajan
SPSumanta K Pal
Sumanta K Pal

24 June 2024
Verified
Book Chapter
Closed access
PDF file
JMJasnoor Malhotra
Jasnoor Malhotra
LMLuis Meza
Luis Meza
AGAmeish Govindarajan
Ameish Govindarajan
SPSumanta K Pal
Sumanta K Pal